A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT00655668 · TERMINATED

Trial details

NCT number: NCT00655668
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

T-cell Non-Hodgkin's Lymphoma

Start date: 2008-03-01
Primary completion: 2010-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.